-
-
Deep brain stimulation significantly increases "on" time, reduces dyskinesias, reduces "off" time, and improves various quality-of-life measures compared with best medical therapy in patients with moderate to advanced Parkinson's disease.
-
The spontaneous development of anti-amyloid antibodies may have an impact on the development of plaques and Alzheimer's disease.
-
Postanoxic status epilepticus does not necessarily imply irreversible and fatal brain injury.
-
Risk factors for spontaneous dissection of carotid and vertebral arteries include smoking, migraine, and a tall, thin body. Women are at increased risk of dissecting multiple arteries.
-
When compared with conventional disease-modifying anti-rheumatic drugs (DMARD), tumor necrosis factor (TNF)-Alpha antibody treatment for rheumatoid arthritis (RA) may increase the risk of herpes zoster.
-
-
The monoclonal antibody, rituximab, appears to benefit patients with myasthenia gravis that is refractory to other modalities.
-
-
Individualization of therapy with pharmacogenetics; the rate vs rhythm debate; the FDA's Risk Evaluation and Mitigation Strategy; FDA actions.
